KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Change in Receivables: 2009-2025

Historic Change in Receivables for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $7.7 million.

  • Idexx Laboratories' Change in Receivables rose 128.62% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.8 million, marking a year-over-year decrease of 1.12%. This contributed to the annual value of $28.3 million for FY2024, which is 47.50% down from last year.
  • Latest data reveals that Idexx Laboratories reported Change in Receivables of $7.7 million as of Q3 2025, which was down 74.04% from $29.6 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Change in Receivables ranged from a high of $54.7 million in Q1 2021 and a low of -$27.8 million during Q4 2024.
  • Over the past 3 years, Idexx Laboratories' median Change in Receivables value was $17.0 million (recorded in 2023), while the average stood at $15.0 million.
  • In the last 5 years, Idexx Laboratories' Change in Receivables spiked by 505.16% in 2022 and then slumped by 3,953.50% in 2024.
  • Quarterly analysis of 5 years shows Idexx Laboratories' Change in Receivables stood at -$15.9 million in 2021, then skyrocketed by 139.83% to $6.3 million in 2022, then crashed by 110.83% to -$686,000 in 2023, then tumbled by 3,953.50% to -$27.8 million in 2024, then surged by 128.62% to $7.7 million in 2025.
  • Its Change in Receivables was $7.7 million in Q3 2025, compared to $29.6 million in Q2 2025 and $45.2 million in Q1 2025.